Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?

Jun 28 2018

• By Mandy Jackson

Finance Watch

Related Content

Forty Seven's IO Antibody Attracts Two Big Pharma Partners

Jan 15 2018

J.P. Morgan Notebook Day 4: CRISPR's Not Worried; Theratechnologies' HIV Niche; And Is Moderna's IPO Coming Soon?

Jan 12 2018

Aptinyx Reaches Milestones, Raises $70m To Develop NMDA Modulators

Dec 18 2017

Finance Watch: Former GSK CEO Witty, R&D Head Slaoui Join VC Firms

Sep 19 2017

The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies

Sep 18 2017

Autolus Raises $80m To Take T-Cell Engineering To The Next Level

Sep 26 2017

BioNotebook: Xoma, Endo, Adamis, CymaBay, Theratechnologies

Dec 14 2013

Finance Watch: Two New VC Funds Raise $500m; One New US IPO; And Galena's 'Strategic Review'

Mar 17 2017

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

Feb 16 2018

Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend

Feb 05 2018

Pregnant Pause: First Phase III Data Hint At Improved Success For ObsEva IVF Drug

Feb 28 2018

Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing

Apr 03 2018

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Apr 15 2018

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

May 03 2018

Venture Funding Deals: Four $100m-Plus Rounds, Including Allogene's $300m

May 05 2018

Galmed To Design Phase III NASH Trial With FDA After Strong Aramchol Data

Jun 14 2018

Pipeline Watch – Updates From EULAR, EHA and ECNP

Jun 25 2018

Finance Watch: Hua Medicine Raises $117.4m While Evaluating A Hong Kong IPO

Apr 06 2018

Theratechnologies Sets $118k Yearly Price For HIV Biologic Trogarzo

Mar 07 2018

Finance Watch: VC Interest Lags At Early Stage – 'Hogwash' Or Evidence-Based?

Mar 06 2018

Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing

Mar 16 2018

Keeping Track: Bristol Tests US FDA’s TMB Tolerance, Celltrion Resubmits Herceptin Biosimilar, Nocdurna Approved At Last

Jun 24 2018

Finance Watch: Rhythm And OptiNose IPOs Bring 2017 Total To 31, Surpassing 2016

Oct 17 2017

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Aug 02 2017

Related Companies

Neon Therapeutics, Inc.

Translate Bio

Tricida, Inc.

Autolus Therapeutics plc

AVROBIO, Inc.

Aptinyx, Inc.

Naurex, Inc.

Allergan plc

Magenta Therapeutics, Inc.

Kezar Life Sciences, Inc.

Xeris Biopharma Holdings, Inc.

Eidos Therapeutics, Inc.

BridgeBio Pharma, Inc.

Forty Seven Inc.

Replimune Group Inc.

Constellation Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

Heron Therapeutics, Inc.

Rhythm Pharmaceuticals, Inc.

Galmed Pharmaceuticals Ltd.

ObsEva SA

Theratechnologies Inc.

Merck KGaA

Aerpio Pharmaceuticals, Inc.

Astria Therapeutics, Inc.

EyePoint Pharmaceuticals, Inc.

Additional Topics

Financing Business Strategies Strategy Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window